These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24328842)

  • 1. Why do patients stay in opioid maintenance treatment?
    Gutwinski S; Bald LK; Gallinat J; Heinz A; Bermpohl F
    Subst Use Misuse; 2014 May; 49(6):694-9. PubMed ID: 24328842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methadone and levomethadone - dosage and side effects].
    Schoofs N; Riemer T; Bald LK; Heinz A; Gallinat J; Bermpohl F; Gutwinski S
    Psychiatr Prax; 2014 Mar; 41(2):82-7. PubMed ID: 24254424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with non-adherence and misuse of opioid maintenance treatment medications and intoxicating drugs among Finnish maintenance treatment patients.
    Launonen E; Wallace I; Kotovirta E; Alho H; Simojoki K
    Drug Alcohol Depend; 2016 May; 162():227-35. PubMed ID: 27068849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heroin or conventional opioid maintenance? The patients' perspective.
    Bald LK; Bermpohl F; Heinz A; Gallinat J; Gutwinski S
    J Addict Med; 2013; 7(6):401-4. PubMed ID: 24145159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid maintenance therapy in Switzerland: an overview of the Swiss IMPROVE study.
    Besson J; Beck T; Wiesbeck G; Hämmig R; Kuntz A; Abid S; Stohler R
    Swiss Med Wkly; 2014; 144():w13933. PubMed ID: 24706398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients.
    Launonen E; Alho H; Kotovirta E; Wallace I; Simojoki K
    Int J Drug Policy; 2015 Sep; 26(9):875-82. PubMed ID: 25934054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing of drugs for attention-deficit hyperactivity disorder in opioid maintenance treatment patients in Norway.
    Karlstad Ø; Furu K; Skurtveit S; Selmer R
    Eur Addict Res; 2014; 20(2):59-65. PubMed ID: 24080771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From methadone to buprenorphine: changes during a 10 year period within a national opioid maintenance treatment programme.
    Riksheim M; Gossop M; Clausen T
    J Subst Abuse Treat; 2014 Mar; 46(3):291-4. PubMed ID: 24210532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with dropout among patients in opioid maintenance treatment (OMT) and predictors of re-entry. A national registry-based study.
    Bukten A; Skurtveit S; Waal H; Clausen T
    Addict Behav; 2014 Oct; 39(10):1504-9. PubMed ID: 24960556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological predictors of retention in a low-threshold methadone maintenance treatment for opioid addicts: a 1-year follow-up study.
    Perreault M; Julien D; White ND; Rabouin D; Lauzon P; Milton D
    Subst Use Misuse; 2015 Jan; 50(1):24-31. PubMed ID: 25245107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased somatic morbidity in the first year after leaving opioid maintenance treatment: results from a Norwegian cohort study.
    Skeie I; Brekke M; Clausen T; Gossop M; Lindbaek M; Reinertsen E; Thoresen M; Waal H
    Eur Addict Res; 2013; 19(4):194-201. PubMed ID: 23257574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study.
    Bukten A; Herskedal A; Skurtveit S; Bramness JG; Clausen T
    Addiction; 2013 Nov; 108(11):1954-61. PubMed ID: 23773400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term consequences of acute pain for patients under methadone or buprenorphine maintenance treatment.
    Bounes V; Palmaro A; Lapeyre-Mestre M; Roussin A
    Pain Physician; 2013; 16(6):E739-47. PubMed ID: 24284855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abstinence orientation and treatment practice: an analysis of German settings providing opioid maintenance therapy.
    Trautmann S; Wittchen HU
    Subst Use Misuse; 2012 Jan; 47(1):22-30. PubMed ID: 22060728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription of analgesics to patients in opioid maintenance therapy: a pharmacoepidemiological study.
    Fredheim OM; Borchgrevink PC; Nordstrand B; Clausen T; Skurtveit S
    Drug Alcohol Depend; 2011 Jul; 116(1-3):158-62. PubMed ID: 21277710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
    Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.